Epitope analysis of myeloperoxidase(MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis

被引:0
|
作者
Fujii, A
Tomizawa, K
Arimura, Y
Nagasawa, T
Ohashi, YY
Hiyama, T
Mizuno, S
Suzuki, K
机构
[1] Natl Inst Infect Dis, NIH, Dept Bioact Mol, Shinyuku Ku, Tokyo 1628640, Japan
[2] Kyorin Univ, Sch Med, Dept Internal Med 1, Tokyo, Japan
[3] Teikoku Hormone, Nat Prod Res Dept, Kawasaki, Kanagawa, Japan
关键词
neutrophils; myeloperoxidase; anti-neutrophil cytoplasmic autoantibodies; (ANCA)-MPO-ANCA; epitope analysis; glomerulonephritis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim and methods: Epitope analysis of sera from 20 patients with myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis was examined by Western blotting using a panel set of recombinant deletion mutants of MPO. Sera from 19 patients reacted with recombinants of MPO heavy chain, whereas no serum reacted with the light chain regions. The high frequency sites were regions on the upstream of Met(341) (Ha region), on the upstream of Met(409) (Hb region) near the N-terminus of the MPO heavy chain and a region on the downstream of Gly(598) (Hg region) near the C-terminus. The epitope recognition profiles were classified into 2 groups. Group Al which had 1 or 2 regions in Ha, Hb and Hg, and group B, which had all 3 regions. Results: Incidence of alveolar hemorrhage (AH) and pulmonary fibrosis (PF) in group A was significantly higher than that in group B (AH: group A 9 of 13 (69.2%), group B 1 of 6 (16.7%) p < 0.05, PF: group A 10 of 13 (76.9%). group B 1 of 6 (16.7%) p < 0.05. AH and/or PH: group A 12 of 13 (92.3%) and group B 1 of 6 (16.7%) p < 0.01). Relapse rate for patients in the inactive stage in group A was significantly higher than that in group B (p < 0.05). T-cell reacted regions were Ha. Hb. Hg and the light chain of MPO recombinant fragments. Higher frequency of HLA typing with MHC class II DR9 was observed. Conclusion: These results indicate that MPO-ANCA recognizes the linear site of the heavy chain of the MPO molecule. The epitope recognition profiles are related to the clinical features. suggesting the pathogenesis of MPO-ANCA-associated glomerulonephritis.
引用
收藏
页码:242 / 252
页数:11
相关论文
共 50 条
  • [21] Clinical outcomes and clinico-pathological correlations in children with MPO-ANCA-associated glomerulonephritis showing renal arteritis
    Zhang, Pei
    Yan, Shi-jun
    Hu, Jian
    Liu, Hai-peng
    Xia, Wei
    Yang, Meng
    Kuang, Qian-huining
    Shi, Kai-li
    Fu, Meng-zhen
    Gao, Chun-lin
    Xia, Zheng-kun
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (06) : 511 - 521
  • [22] Anti-neutrophil cytoplasm autoantibodies (ANCA). The need for specific and sensitive assays
    Baslund, B
    Petersen, J
    AUTOIMMUNITY, 1998, 27 (04) : 231 - 238
  • [23] Tacrolimus as a reinforcement therapy for a patient with MPO-ANCA-associated diffuse alveolar hemorrhage
    Kawasaki, Satoko
    Nakamura, Hideki
    Honda, Emi
    Iwanaga, Nozomi
    Kawakami, Atsushi
    Ida, Hiroaki
    Origuchi, Tomoki
    Honda, Shoko
    Tsuchihashi, Yoshiko
    Yoshimine, Hiroyuki
    Eguchi, Katsumi
    CLINICAL RHEUMATOLOGY, 2007, 26 (07) : 1211 - 1214
  • [24] Characterization of interstitial infiltrates in MPO and PR3 anti-neutrophil cytoplasmic antibody glomerulonephritis
    Kant, Sam
    Arend, Lois J.
    Gapud, Eric
    Seo, Phil
    Geetha, Duvuru
    JOURNAL OF NEPHROLOGY, 2022, 35 (04) : 1171 - 1175
  • [25] Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go?
    Kallenberg, C. G. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 1 - 3
  • [26] Development of Anti-neutrophil Cytoplasmic Antibodies (ANCA) and Vasculitis in BALB/c Mice: A Prototype of Human ANCA Associated Disease
    Pradhan, Vandana D.
    Ghosh, K.
    JOURNAL OF APPLIED ANIMAL RESEARCH, 2009, 36 (02) : 297 - 301
  • [27] Risk factors for treatment resistance and relapse of Chinese patients with MPO-ANCA-associated vasculitis
    Huang, Li
    Shen, Chanjuan
    Zhong, Yong
    Ooi, Joshua D.
    Zhou, Ya-Ou
    Chen, Jin-Biao
    Wu, Ting
    Meng, Ting
    Xiao, Zhou
    Lin, Wei
    Ao, Xiang
    Xiao, Xiangcheng
    Zhou, Qiaoling
    Xiao, Ping
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (02) : 199 - 206
  • [28] Risk factors for treatment resistance and relapse of Chinese patients with MPO-ANCA-associated vasculitis
    Li Huang
    Chanjuan Shen
    Yong Zhong
    Joshua D. Ooi
    Ya-Ou Zhou
    Jin-Biao Chen
    Ting Wu
    Ting Meng
    Zhou Xiao
    Wei Lin
    Xiang Ao
    Xiangcheng Xiao
    Qiaoling Zhou
    Ping Xiao
    Clinical and Experimental Medicine, 2020, 20 : 199 - 206
  • [29] Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies
    Guilpain, Philippe
    Servettaz, Amelie
    Batteux, Frederic
    Guillevin, Loic
    Mouthon, Luc
    AUTOIMMUNITY REVIEWS, 2008, 7 (06) : 421 - 425
  • [30] Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis
    Niles, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 27 - 30